Genetic Study of Familial Factors in Patients With Colon Cancer
Status: | Completed |
---|---|
Conditions: | Colorectal Cancer, Colorectal Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | Any - 70 |
Updated: | 7/14/2016 |
Start Date: | December 2001 |
End Date: | October 2010 |
Familial Factors in the Development of Colon Cancer
RATIONALE: Genetic studies may help in understanding the genetic processes involved in the
development of some types of cancer.
PURPOSE: Clinical trial to study the cancer-related genes in patients who have colon cancer
or adenomatous polyps.
development of some types of cancer.
PURPOSE: Clinical trial to study the cancer-related genes in patients who have colon cancer
or adenomatous polyps.
OBJECTIVES:
- Identify human colon neoplasia susceptibility genes in patients with colon cancer or
adenomatous polyps.
- Correlate the inheritance of novel susceptibility alleles for adenomatous polyposis of
the colon with colon neoplasia in these patients.
- Correlate colon neoplasia susceptibility with the presence of COX-2, sPLA2, and DNMT
genes in these patients.
- Identify a novel gene that governs increased susceptibility to colon adenoma and cancer
in the genome of these patients.
- Identify human colon neoplasia susceptibility genes in patients with colon cancer or
adenomatous polyps.
- Correlate the inheritance of novel susceptibility alleles for adenomatous polyposis of
the colon with colon neoplasia in these patients.
- Correlate colon neoplasia susceptibility with the presence of COX-2, sPLA2, and DNMT
genes in these patients.
- Identify a novel gene that governs increased susceptibility to colon adenoma and cancer
in the genome of these patients.
DISEASE CHARACTERISTICS:
- Diagnosis of colon cancer or polyps at age 70 or under
- Has a living full sibling with diagnosis of colon cancer or polyps at age 70 or under
- No history of familial adenomatous polyposis syndrome
- No hereditary nonpolyposis colon cancer, according to Amsterdam criteria
- No known I1370K adenomatous polyposis of the colon susceptibility variant
- Enrolled on 1 of the following clinical trials:
- CLB-9581
- CLB-89803
- CLB-80001 NOTE: Patients do not need to be receiving protocol therapy. Patients
who are outside the treatment protocol's follow-up range are eligible. Patients
who discontinued therapy for any reason, including toxic effects, are eligible.
PATIENT CHARACTERISTICS:
Age
- 70 and under at diagnosis
Other
- No significant psychiatric illness that would preclude giving informed consent
- No inflammatory bowel disease (in patient or sibling)
We found this trial at
1
site
Click here to add this to my saved trials